NO20071685L

Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

Abstract

Forbindelser med formel (I) og (I '^) er nyttige som 1 IBETA-HSDl-inhibitorer for behandling av obesitet.

Term

No projected expiry on record.

  1. Priority
  2. Filed and published
  3. Today

35 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
04104147European Patent Office (EPO)A
60784004United States of AmericaP
2005054198European Patent Office (EPO)W
04104147–––
60607840–––
EP20040104147–––
PCTEP05054198–––
US20040607840P–––
WO2005EP54198–––

Members35

Family members, oldest first
DocumentOfficeKind
AU2005279209A1AustraliaA1
CA2576850A1CanadaA1
WO2006024628A1World Intellectual Property Organization (WIPO)A1
TW200626549ATaiwan Province of ChinaA
AR050540A1ArgentinaA1
NO20071685LThis recordNorwayL
EP1786774A1European Patent Office (EPO)A1
KR20070067111ARepublic of KoreaA
IL181581A0IsraelA0
CN101039908AChinaA
JP2008511581AJapanA
US2008214597A1United States of AmericaA1
HK1112618AHong Kong, ChinaA
HK1112618A1Hong Kong, ChinaA1
RU2007111711ARussian FederationA
EP1786774B1European Patent Office (EPO)B1
AT445600TAustriaT
ATE445600T1AustriaT1
DE602005017159D1GermanyD1
ES2334246T3SpainT3
MY141198AMalaysiaA
RU2386617C2Russian FederationC2
CN101039908BChinaB
AU2005279209B2AustraliaB2
TWI365871BTaiwan Province of ChinaB
KR101197672B1Republic of KoreaB1
JP5137574B2JapanB2
CA2576850CCanadaC
US8563591B2United States of AmericaB2
US2014179732A1United States of AmericaA1
US9150512B2United States of AmericaB2
US2016002229A1United States of AmericaA1
US9422284B2United States of AmericaB2
US2016318865A1United States of AmericaA1
US9630921B2United States of AmericaB2